Advanced search
Publication Cover
The Journal of Maternal-Fetal & Neonatal Medicine Volume 35, 2022 - Issue 25
Submit an article Journal homepage
370
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Remdesivir use in pregnancy during the SARS-CoV-2 pandemic

Rigoberto Gutierreza Department of Pediatrics, Phoenix Children’s Hospital, Phoenix, AZ, USA
,
Hector Mendez-Figueroab Department of Obstetrics, Gynecology and Reproductive Sciences, McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USACorrespondence[email protected]
,
John G. Biebighauserc McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA
,
Asha Bhalwalb Department of Obstetrics, Gynecology and Reproductive Sciences, McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA
,
Beth L. Pinelesb Department of Obstetrics, Gynecology and Reproductive Sciences, McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA
&
Suneet P. Chauhanb Department of Obstetrics, Gynecology and Reproductive Sciences, McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA
Pages 9445-9451 | Received 23 Oct 2021, Accepted 09 Feb 2022, Published online: 15 Feb 2022

References

  • Weekly Epidemiological Update on COVID-19; 2021 [cited 2021 Jul 1]. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---29-june-2021
  • Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809–815.
  • Wiersinga WJ, Rhodes A, Cheng AC, et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782–793.
  • Naqvi M, Zakowski P, Glucksman L, et al. Tocilizumab and remdesivir in a pregnant patient with coronavirus disease 2019 (COVID-19). Obstet Gynecol. 2020;136(5):1025–1029.
  • Mullins E, Hudak ML, Banerjee J, et al. Pregnancy and neonatal outcomes of COVID-19: coreporting of common outcomes from PAN-COVID and AAP-SONPM registries. Ultrasound Obstet Gynecol. 2021;57(4):573–581.
  • Syeda S, Baptiste C, Breslin N, et al. The clinical course of COVID in pregnancy. Semin Perinatol. 2020;44(7):151284.
  • Yang J, D’Souza R, Kharrat A, et al. COVID-19 pandemic and population-level pregnancy and neonatal outcomes: a living systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2021;100(10):1756–1770.
  • Pineles BL, Goodman KE, Pineles L, et al. In-hospital mortality in a cohort of hospitalized pregnant and nonpregnant patients with COVID-19. Ann Intern Med. 2021;174(8):1186–1188.
  • Eastman RT, Roth JS, Brimacombe KR, et al. Remdesivir: a review of its discovery and development leading to emergency use authorization for treatment of COVID-19. ACS Cent Sci. 2020;6(5):672–683.
  • Santoro MG, Carafoli E. Remdesivir: from Ebola to COVID-19. Biochem Biophys Res Commun. 2021;538:145–150.
  • Mulangu S, Dodd LE, Davey RT Jr., et al. A randomized, controlled trial of Ebola virus disease therapeutics. N Engl J Med. 2019;381(24):2293–2303.
  • McCoy JA, Short WR, Srinivas SK, et al. Compassionate use of remdesivir for treatment of severe coronavirus disease 2019 in pregnant women at a United States Academic Center. Am J Obstet Gynecol MFM. 2020;2(3):100164.
  • Igbinosa I, Miller S, Bianco K, et al. Use of remdesivir for pregnant patients with severe novel coronavirus disease 2019. Am J Obstet Gynecol. 2020;223(5):768–770.
  • Burwick RM, Yawetz S, Stephenson KE, et al. Compassionate use of remdesivir in pregnant women with severe covid-19. Clin Infect Dis. 2020;73(11):e3996–e4004.
  • Maldarelli GA, Savage M, Mazur S, et al. Remdesivir treatment for severe COVID-19 in third-trimester pregnancy: case report and management discussion. Open Forum Infect Dis. 2020;7(9):ofaa345.
  • Harris PA, Taylor R, Thielke R, et al. Research Electronic Data Capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381.
  • Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.
  • NIH. 2021; [cited 2021 Jun 1]. Available from: https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/
  • Pineles BL, Stephens A, Narendran LM, et al. The relationship between delivery and the PaO2/FiO2 ratio in COVID-19: a cohort study. BJOG. 2021;129(3):493–499.
  • von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–1457.
  • Anderson J, Schauer J, Bryant S, et al. The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: a case report. Case Rep Womens Health. 2020;27:e00221.
  • Pelayo J, Pugliese G, Salacup G, et al. Severe COVID-19 in third trimester pregnancy: multidisciplinary approach. Case Rep Crit Care. 2020;2020:8889487.
  • Jacobson J, Antony K, Beninati M, et al. Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: a case report. Case Rep Womens Health. 2021;29:e00273.
  • Zampino R, Mele F, Florio LL, et al. Liver injury in remdesivir-treated COVID-19 patients. Hepatol Int. 2020;14(5):881–883.
  • Effenberger M, Grander C, Grabherr F, et al. Systemic inflammation as fuel for acute liver injury in COVID-19. Dig Liver Dis. 2021;53(2):158–165.
  • Conde-Agudelo A, Romero R. SARS-COV-2 infection during pregnancy and risk of preeclampsia: a systematic review and meta-analysis. Am J Obstet Gynecol. 2021;226(1):68–89.e3.
  • Lam H, Lacasse A. Combination of remdesivir, corticosteroid, and convalescent plasma for severe COVID-19 in periviable pregnancy. Infect Dis Clin Pract. 2020;28(6):e21–e23.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.